Sodium thiosulfate shots for abnormal calcium or bone spots
Part of Bones, joints & muscles, Brain & nervous system, Skin clinical trials.
This pilot study tests a medicine called sodium thiosulfate (given as a skin shot) to treat abnormal calcium or bone formation in places they don’t belong. It’s meant for people whose condition is causing significant problems, and who are not planning surgery for the next year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 2 or older with abnormal calcium/bone in the wrong place from dermatomyositis, systemic sclerosis, or iPPSD2
- A team has agreed that your abnormal calcium/bone needs treatment because it causes major harm or limits function
- You do not plan to have surgery to remove these areas within the next 12 months
- You cannot be allergic to sodium thiosulfate or the shot ingredients
- If you could become pregnant, you must use highly effective birth control during treatment and for 91 days after the last shot
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if injecting a medication called STS directly into calcium deposits can relieve pain and symptoms. It may help patients with scleroderma or related conditions who have painful calcium lumps.
This study tests whether an added treatment called pyrophosphate can reduce calcium deposits in the skin caused by systemic sclerosis (SSC). You may be able to join if you meet standard diagnosis criteria and don’t have certain heart- and thyroid-related issues.
This trial tests a new cell injection treatment (RY_SW01) for people with systemic sclerosis (a condition causing skin thickening and organ issues). It aims to see if the therapy can improve skin hardening and overall symptoms.
This Phase 2 study tests itacitinib, a targeted medicine, to see if it can safely improve diffuse systemic sclerosis (a hardening/tightening of the skin and organ involvement). You may be eligible if you have active disease or it has been present less than 3 years.
This Phase 2 study tests whether an “autologous” stem cell transplant—using your own stem cells—can reduce systemic sclerosis disease activity. It is mainly for children, teens, and young adults whose disease did not improve despite standard medicines.
This Phase 2 study tests whether injections under the skin can help heal painful, poor-circulation (ischemic) finger ulcers caused by scleroderma. It is for people whose ulcers have not improved with usual care.
Hear when a new Systemic Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.